Skip to main content

Rosetta, Iconix to Integrate Resolver with DrugMatrix

NEW YORK, June 20 (GenomeWeb News) - Rosetta Biosoftware and Iconix Pharmaceuticals said today that they will integrate Rosetta's Resolver gene-expression data analysis system and Iconix' DrugMatrix database of toxicogenomics profiles.

 

The collaboration will enable researchers to use the Resolver system to analyze and manage data from DrugMatrix, along with data from other sources, the companies said.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.